If you attended a major life sciences event in 2010, you probably didn't see much mention of 3D cell culture research in posters or presentations. Back then, it was an academic curiosity, not something scientists took seriously — at least not in big pharma.
What a difference a decade makes. Today, 3D cell culture isn't just the stuff of obscure posters or presentations; entire conferences examine the promise of 3D. And big pharma is getting involved: The 3D Cell Culture 2020 conference in Germany, which was postponed in response to the coronavirus pandemic, was slated to include pharmaceutical voices on its planning committee and in its lectures.
"Over the years, interest has gone up," said Hilary Sherman, a senior applications scientist with Corning Life Sciences. "And then at SLAS, which we recently attended earlier this year, it just seemed like everybody was talking about 3D."